KRAS and colorectal cancer: We examined primary organoids from a genetically engineered mouse model of colorectal cancer, intestine-specific mutant K-ras, loss of TP53 and activation of Notch signalling (villinCreERKrasG12D/+Trp53fl/flRosa26N1icd/+; KPN)54.